Cleared Traditional

K902038 - PATHO DX STREP D

K902038 is the FDA 510(k) clearance for PATHO DX STREP D by Diagnostic Products Corp.. It is a Class 1 Immunology device (product code GTZ) cleared through the Traditional 510(k) pathway after a 17-day FDA review.

K902038 · Diagnostic Products Corp. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1990
Decision
17d
Days
Class 1
Risk

K902038 is an FDA 510(k) clearance for the PATHO DX STREP D. Classified as Antisera, All Groups, Streptococcus Spp. (product code GTZ), Class I - General Controls.

Submitted by Diagnostic Products Corp. (Los Angeles, US). The FDA issued a Cleared decision on May 21, 1990 after a review of 17 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.3740 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Diagnostic Products Corp. devices

Submission Details

510(k) Number K902038 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 04, 1990
Decision Date May 21, 1990
Days to Decision 17 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
87d faster than avg
Panel avg: 104d · This submission: 17d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code GTZ Antisera, All Groups, Streptococcus Spp.
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3740
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GTZ Antisera, All Groups, Streptococcus Spp.

All 55
Devices cleared under the same product code (GTZ) and FDA review panel - the closest regulatory comparables to K902038.
GROUP A STREP POSITIVE AND NEGATIVE CONTROLS
K912868 · Quidel Corp. · Aug 1991
ICON STREP B IMMUNOENZYMETRIC ASSAY
K911417 · Hybritech, Inc. · Jul 1991
REDITEST STREP A TEST KIT
K903194 · Boehringer Mannheim Corp. · Aug 1990
TESTPACK PLUS STREP A
K901274 · Abbott Laboratories · May 1990
QUIDEL GROUP B STREP TEST
K896265 · Quidel Corp. · Feb 1990
VENTRESIGN STREP A TEST
K897083 · Ventrex Laboratories, Inc. · Jan 1990